Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2009 1
2010 4
2011 4
2012 6
2013 4
2014 2
2015 3
2016 2
2017 2
2018 3
2019 3
2020 5
2021 7
2022 3
2023 4

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Biomarker-Oriented Therapy in Bladder and Renal Cancer.
Scholtes MP, Alberts AR, Iflé IG, Verhagen PCMS, van der Veldt AAM, Zuiverloon TCM. Scholtes MP, et al. Among authors: zuiverloon tcm. Int J Mol Sci. 2021 Mar 11;22(6):2832. doi: 10.3390/ijms22062832. Int J Mol Sci. 2021. PMID: 33799514 Free PMC article. Review.
Open versus minimal invasive radical cystectomy.
van Diepen DC, Zuiverloon TCM, Klaver SO, Boormans JL. van Diepen DC, et al. Among authors: zuiverloon tcm. Transl Androl Urol. 2020 Dec;9(6):2471-2473. doi: 10.21037/tau-20-878. Transl Androl Urol. 2020. PMID: 33457218 Free PMC article. No abstract available.
Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer.
de Jong FC, Rutten VC, Zuiverloon TCM, Theodorescu D. de Jong FC, et al. Among authors: zuiverloon tcm. Int J Mol Sci. 2021 Mar 10;22(6):2800. doi: 10.3390/ijms22062800. Int J Mol Sci. 2021. PMID: 33802033 Free PMC article. Review.
RNA-based urinary assays for non-muscle invasive bladder cancer.
Pijpers OM, de Jong JJ, Zuiverloon TCM, Boormans JL. Pijpers OM, et al. Among authors: zuiverloon tcm. Curr Opin Urol. 2022 Sep 1;32(5):523-530. doi: 10.1097/MOU.0000000000001018. Curr Opin Urol. 2022. PMID: 35916010 Review.
PD-L1 Antibody Comparison in Urothelial Carcinoma.
Rijnders M, van der Veldt AAM, Zuiverloon TCM, Grünberg K, Thunnissen E, de Wit R, van Leenders GJLH. Rijnders M, et al. Among authors: zuiverloon tcm. Eur Urol. 2019 Mar;75(3):538-540. doi: 10.1016/j.eururo.2018.11.002. Epub 2018 Nov 27. Eur Urol. 2019. PMID: 30497882 No abstract available.
Targeted therapies in bladder cancer: an overview of in vivo research.
van Kessel KE, Zuiverloon TC, Alberts AR, Boormans JL, Zwarthoff EC. van Kessel KE, et al. Among authors: zuiverloon tc. Nat Rev Urol. 2015 Dec;12(12):681-94. doi: 10.1038/nrurol.2015.231. Epub 2015 Sep 22. Nat Rev Urol. 2015. PMID: 26390971 Review.
41 results